Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More
Trade Brains
OCTOBER 6, 2023
It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. Following global demand, Cipla has deepened its portfolio for the US markets with continued traction in the respiratory franchise and expansion of its peptide portfolio with increased market share in the Company’s first Lanreotide injection.
Let's personalize your content